EUVIMEDEUVIMED entdecken
Crossref

Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients

Monika Długosz-Danecka, Andrzej Jaroszyński, Wojciech Jurczak

OncoReview · 2019

DOI: 10.24292/01.or.271218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Monika Długosz-Danecka und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Długosz-Danecka, M., Jaroszyński, A., & Jurczak, W. (2019). Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients. OncoReview. https://doi.org/10.24292/01.or.271218

Vancouver

Długosz-Danecka M, Jaroszyński A, Jurczak W. Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients. OncoReview. 2019. doi:10.24292/01.or.271218

BibTeX
@article{DugoszDanecka2019,
  author = {Długosz-Danecka, Monika and Jaroszyński, Andrzej and Jurczak, Wojciech},
  title = {Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients},
  journal = {OncoReview},
  year = {2019},
  doi = {10.24292/01.or.271218}
}
Kostenlos starten →